Key facts
- Hunan Luying Technology’s last known valuation is $15.6M (Dec 2025).
- It has raised $4.3M; the latest was Seed Round ($4.3M) in Dec 2025.
- Notable investors include Guangzhou Jinkong Fund, Hunan Guochuang Industrial Investment, AVE Technology.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Hunan Luying Technology
- ·The full record, as it builds
Funding rounds
No funding rounds for Hunan Luying Technology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Hunan Luying Technology
Developer and manufacturer of high-resolution Single Photon Emission Computed Tomography (SPECT) scanners and core components designed for molecular imaging diagnostics. The company provides domestically produced SPECT and SPECT/Computed Tomography (SPECT/CT) systems and key modules, enabling healthcare providers with precise, safe, cost-effective, and accessible nuclear medicine imaging solutions.
- Sector
- Healthcare
- HQ
- Changsha, China
- Founded
- 2025
- Ownership
- Privately Held (backing)
Hunan Luying Technology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Hunan Luying Technology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Hunan Luying Technology in its N-PORT filings yet. We sweep new filings monthly.